Vanguard Asset Management »

Day One Biopharmaceuticals I shares owned by Vanguard Asset Management

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Vanguard Asset Management from 13F filings

Historical chart of Vanguard Asset Management investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Vanguard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1M 51k 21.44

More positions owned by Vanguard Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Astrazeneca Ord (AZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)

View all positions for Vanguard Asset Management

Top funds holding Day One Biopharmaceuticals I

BlackRock
Atlas Venture Life Science Advisors
Vanguard Group
FMR
Glazer Capital
State Street Corporation
Deerfield Management Company
Vanguard Capital Management
Balyasny Asset Management
CNH Partners
UBS Group
Vanguard Portfolio Management
Geode Capital Management
Millennium Management
Bank of America Corporation

View all funds holding Day One Biopharmaceuticals I